Substance use disorder (SUD) treatment could benefit from pharmacists’ accessibility and expertise, NACDS wrote in detailed letters to 15 Medicaid program directors.
NACDS has elevated and enhanced three key functions to integrate with NACDS’ campaign-style approach to issue advocacy.
NACDS stresses the importance of diverse opioid disposal options and a comprehensive approach to opioid-abuse prevention, while caring for those in pain.
As the Centers for Medicare & Medicaid Services studies the treatment and prevention of opioid addiction, NACDS has submitted comments on addressing the epidemic and caring for pain sufferers.
In an article in the Journal of Managed Care & Specialty Pharmacy, authors from University of Pittsburgh Medical Center, Humana, and the University of Pittsburgh cite pharmacy's value and issue recommendations by which patients can benefit more.
Grammy Award-nominated entertainer to headline evening dedicated to improving patient outcomes and public health
NACDS is deploying its 30-second message regarding pharmacy’s commitment, and recognizing pharmacists’ dedication, to serve as part of the solution.
Session will assess more opportunities for collaboration and identify replicable healthcare innovations to improve overall patient health outcomes
In comments to CMS, NACDS says weakening of state access standards is flawed policymaking, and threatens to harm patient health and increase Medicaid costs
Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues
